|
|
|
|
Volcano Corporation
Presentation at JMP Conference to be Webcast
|
 |
 May
13,
2009 -- San Diego -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the Eighth Annual JMP Securities Research Conference on Monday, May 18.
The presentation by John Dahldorf, chief financial officer, will begin at 3:00 p.m., Pacific Daylight Time (6:00 p.m., Eastern Daylight Time).
The presentation will be available through the conference website at http://www.wsw.com/webcast/jmp8/volc/ and via the company's website at www.volcanocorp.com.
Volcano Corporation (Nasdaq: VOLC) offers a
broad suite of devices designed to facilitate endovascular procedures,
enhance the diagnosis of vascular and structural heart disease and
guide optimal therapies. The company's intravascular ultrasound (IVUS)
product line includes ultrasound consoles that can be integrated directly
into virtually any modern cath lab. Volcano IVUS offers unique features,
including both single-use phased array and rotational IVUS imaging
catheters, and advanced functionality options, such as VH®
IVUS tissue characterization and ChromaFlo®.
Volcano also provides functional measurement (FM) consoles and single-use
pressure and flow guide wires and is developing a line of ultra-high
resolution Optical Coherence Tomography (OCT) systems and catheters.
Currently, more than 4,200 Volcano IVUS and FM systems are installed
worldwide and approximately half of Volcano's revenues are derived
from outside the United States. Volcano also develops and manufactures
optical monitors, lasers and optical engines used in OCT imaging systems
and advanced photonic components and subsystems used in spectroscopy
and other industrial applications. For more information, visit the
company's website at http://www.volcanocorp.com.
Source: Volcano
Corporation
|
|
